Wound Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 414 Published: June 07, 2022 Report Code: GDME1379EPD

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • FAQ
  • Listen
    https://www.ispeech.org/text.to.speech

Wound closure devices are used to close wounds that occur due to injuries or surgical procedures. This category includes topical absorbable hemostats, tissue sealants, wound closure strips, ligating clips, tissue adhesives and surgical adhesion barriers.

The wound closure devices pipeline market research report including stages of development, segments, region and countries, regulatory path, and key companies, provides comprehensive information about the wound closure devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

What are the key territories in the wound closure devices market?

The key territories in the wound closure devices market are United States, Europe, China, South Korea, Japan, Israel, India, Singapore, Taiwan, the United Kingdom. The US has the highest number of pipeline products in the wound closure devices market.

Wound closure devices market, by territories

Wound closure devices market, by territories

For more territory insights, download a free report sample

What are the key segments in the wound closure devices market?

The key segments in the wound closure devices market are Topical Absorbable Hemostats, Tissue Sealants, Tissue Adhesives, Surgical Adhesion Barriers, Synthetic Tissue Sealants, Gel Surgical Adhesion Barriers, Collagen Based Hemostats, Fibrin Based Tissue Sealants, Oxidized Regenerated Cellulose Based Hemostats, Thrombin Based Hemostats, and Membrane Surgical Adhesion Barriers. Topical Absorbable Hemostats has the highest number of pipeline products.

Wound closure devices market, by segments

Wound closure devices market, by segments

For more segment insights, download a free report sample

What are the key regulatory paths in the wound closure devices market?

The key regulatory paths in the wound closure devices market are 510(k), CE, PMA, NMPA, MDITAC, ICAC, Ninsho, HAS, MDL, BOPA, and others. 510(k) has the highest number of pipeline products.

Wound closure devices market, by regulatory path

Wound closure devices market, by regulatory pathTo know more about key companies, download a free report sample

Which are the key companies in the wound closure devices market?

The key companies in the wound closure devices market are 3-D Matrix Ltd, Abyrx, Inc., ACell Inc, Acro Biomedical Co Ltd, Actamax Surgical Materials LLC, Adhesys Medical GmbH, Advanced Biotech Products Pvt Ltd, Advanced Medical Solutions Group plc, AFYX Therapeutics A/S, and Alafair Biosciences Inc.

Market report overview

Key territories The United States, Europe, China, South Korea, Japan, Israel, India, Singapore, Taiwan, the United Kingdom
Key segments Topical Absorbable Hemostats, Tissue Sealants, Tissue Adhesives, Surgical Adhesion Barriers, Synthetic Tissue Sealants, Gel Surgical Adhesion Barriers, Collagen Based Hemostats, Fibrin Based Tissue Sealants, Oxidized Regenerated Cellulose Based Hemostats, Thrombin Based Hemostats, and Membrane Surgical Adhesion Barriers
Key regulatory paths 510(k), CE, PMA, NMPA, MDITAC, ICAC, Ninsho, HAS, MDL, BOPA, and Others
Key companies 3-D Matrix Ltd, Abyrx, Inc., ACell Inc, Acro Biomedical Co Ltd, Actamax Surgical Materials LLC, Adhesys Medical GmbH, Advanced Biotech Products Pvt Ltd, Advanced Medical Solutions Group plc, AFYX Therapeutics A/S, and Alafair Biosciences Inc

Scope

  • Extensive coverage of the Wound Closure Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities.
  • The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Wound Closure Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

3-D Matrix Ltd

Abyrx, Inc.

ACell Inc

Acro Biomedical Co Ltd

Actamax Surgical Materials LLC

Adhesys Medical GmbH

Advanced Biotech Products Pvt Ltd

Advanced Medical Solutions Group plc

AFYX Therapeutics A/S

Alafair Biosciences Inc

Albert Ludwigs University of Freiburg

Aleo BME Inc

Alumend LLC

Angiotech Pharmaceuticals Inc

Anika Therapeutics Inc

APRUS Bio-Medical Innovations Pvt Ltd

ARC Medical Devices Inc

Arch Therapeutics Inc

Arizona State University

Artivion Inc

Aura Medsystems, Inc.

BaroStitch

Baxter Healthcare Corp

Baxter International Inc

Bayer AG

Bergen Medical Products Inc

Beth Israel Deaconess Medical Center

BioActive Polymers in Lund AB

BioDevek Inc

Biomedica Management Corp

Biom’Up SAS

BNC Korea Co Ltd

Borayer Biotechnology Co Ltd

Boston University

Calmare Therapeutics Inc

CardioCommand Inc

Cellphire Inc

Ceramicos Para Aplicacoes Medicas SA

Clemson University

Cohera Medical Inc

Columbia University

Covalent Medical, Inc. (Inactive)

Covalon Technologies Ltd

Covidien Ltd

CR Bard Inc

Cresilon Inc

Department of Biomedical Engineering Columbia University

DSM Biomedical BV

Duke University

Eidgenossische Materialprufungs- und Forschungsanstalt

Elastagen Pty Ltd

Emory University

Endomedix Incorporated

Entegrion Inc

Ethicon Endo-Surgery Inc

Ethicon US LLC

ETX Pharma Inc

FzioMed Inc

Gamma Diagnostics Inc

GATT Technologies BV

Genzyme Corp

Haemostatix Ltd

Hangzhou Kangji Medical Instrument Co Ltd

Hemostasis LLC

HLL Lifecare Ltd

HydroGlaze BV

HyperBranch Medical Technology Inc

Ichor Sciences LLC

Innocoll Technologies Ltd (Inactive)

Institute of Molecular Biology of Parana

InVivo Therapeutics Corp

IonMed Ltd.

Jiangxi Boenruier Biotechnology Co Ltd

Johns Hopkins University

Keratin Biosciences Inc

Kollodis BioSciences Inc

Kuros Biosciences AG

Kytogenics Pharmaceuticals Inc

Lap IQ Inc

Laser Tissue Welding, Inc.

Latch Medical Ltd

Leader Biomedical Europe BV

Lenvitz Medical Solutions Pvt Ltd

Life Care Medical Devices Ltd

Luna Innovations Inc

Magen OrthoMed Ltd

Massachusetts Institute of Technology

Maxigen Biotech Inc

Medcura Inc

Medisse BV (Inactive)

Meril Life Sciences Pvt Ltd

MLM Biologics Inc

N8 Medical LLC

Nanyang Technological University

National University of Ireland Galway

National University of Singapore

Northwestern University

Nurami Medical Ltd

OptMed, Inc.

PetVivo Holdings Inc

Pharming Group NV

Polyganics BV

PolyNovo Biomaterials Pty Ltd

Progress and Health Foundation

Protege Biomedical LLC

Protein Polymer Technologies Inc (Inactive)

Purdue University

Radiation Monitoring Devices Inc

Regenics AS

Resorba GmbH

Rice University

Rutgers The State University of New Jersey

Samyang Biopharmaceuticals Corp

Sanofi Biosurgery Inc

Sea Run Holdings Inc

Sealantis Ltd.

Seikagaku Corp

Seraffix Ltd

Shanghai Haohai Biological Technology Co Ltd

Sporogenics Pte Ltd

St Teresa Medical Inc

Stanford University

Starling Surgical

STB Lifesaving Technologies

Surgical Energetics LLC

Surgical Sealants, Inc.

Tectum

Teijin Pharma Ltd

Tetratherix Pty Ltd

Texas A&M University

The Medicines Co

TheraCell Inc

Therus Corporation

Thrombotargets Corp

Tissium SA

Toray Medical Co Ltd

Tribos LLC

Tricol Biomedical Inc

TYBR Health Inc

United Health Products, Inc.

University of Akron

University of Grenoble Alpes

University of Kansas

University of Minnesota

University of North Carolina at Chapel Hill

University of Pennsylvania

University of Toledo

Virginia Commonwealth University

WoundZipper Inc

Xcede Technologies Inc

Yale University

Yantai Zhenghai Biological Technology Co Ltd

Z-Medica LLC

ZSX Medical LLC

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 12

|1.2 List of Figures 25

2 Introduction 26

2.1 Wound Closure Devices Overview 26

3 Products under Development 29

3.1 Wound Closure Devices – Pipeline Products by Stage of Development 29

3.2 Wound Closure Devices – Pipeline Products by Segment 30

3.3 Wound Closure Devices – Pipeline Products by Territory 32

3.4 Wound Closure Devices – Pipeline Products by Regulatory Path 34

3.5 Wound Closure Devices – Pipeline Products by Estimated Approval Date 35

3.6 Wound Closure Devices – Ongoing Clinical Trials 36

4 Wound Closure Devices – Pipeline Products under Development by Companies 37

4.1 Wound Closure Devices Companies – Pipeline Products by Stage of Development 37

4.2 Wound Closure Devices – Pipeline Products by Stage of Development 43

5 Wound Closure Devices Companies and Product Overview 49

5.1 3-D Matrix Ltd Company Overview 49

5.1.1 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.2 Abyrx, Inc. Company Overview 55

5.2.1 Abyrx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

5.3 ACell Inc Company Overview 56

5.3.1 ACell Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.4 Acro Biomedical Co Ltd Company Overview 58

5.4.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.5 Actamax Surgical Materials LLC Company Overview 59

5.5.1 Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.6 Adhesys Medical GmbH Company Overview 62

5.6.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 62

5.7 Advanced Biotech Products Pvt Ltd Company Overview 63

5.7.1 Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.8 Advanced Medical Solutions Group plc Company Overview 64

5.8.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 64

5.9 AFYX Therapeutics A/S Company Overview 69

5.9.1 AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview 69

5.10 Alafair Biosciences Inc Company Overview 70

5.10.1 Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.11 Albert Ludwigs University of Freiburg Company Overview 71

5.11.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 71

5.12 Aleo BME Inc Company Overview 72

5.12.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.13 Alumend LLC Company Overview 75

5.13.1 Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview 75

5.14 Angiotech Pharmaceuticals Inc Company Overview 76

5.14.1 Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.15 Anika Therapeutics Inc Company Overview 78

5.15.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.16 APRUS Bio-Medical Innovations Pvt Ltd Company Overview 80

5.16.1 APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.17 ARC Medical Devices Inc Company Overview 81

5.17.1 ARC Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.18 Arch Therapeutics Inc Company Overview 82

5.18.1 Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.19 Arizona State University Company Overview 90

5.19.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 90

5.20 Artivion Inc Company Overview 91

5.20.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.21 Aura Medsystems, Inc. Company Overview 95

5.21.1 Aura Medsystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95

5.22 BaroStitch Company Overview 96

5.22.1 BaroStitch Pipeline Products & Ongoing Clinical Trials Overview 96

5.23 Baxter Healthcare Corp Company Overview 97

5.23.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 97

5.24 Baxter International Inc Company Overview 99

5.24.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.25 Bayer AG Company Overview 102

5.25.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 102

5.26 Bergen Medical Products Inc Company Overview 103

5.26.1 Bergen Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.27 Beth Israel Deaconess Medical Center Company Overview 104

5.27.1 Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 104

5.28 BioActive Polymers in Lund AB Company Overview 105

5.28.1 BioActive Polymers in Lund AB Pipeline Products & Ongoing Clinical Trials Overview 105

5.29 BioDevek Inc Company Overview 106

5.29.1 BioDevek Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.30 Biomedica Management Corp Company Overview 107

5.30.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 107

5.31 Biom’Up SAS Company Overview 110

5.31.1 Biom’Up SAS Pipeline Products & Ongoing Clinical Trials Overview 110

5.32 BNC Korea Co Ltd Company Overview 112

5.32.1 BNC Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

5.33 Borayer Biotechnology Co Ltd Company Overview 114

5.33.1 Borayer Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

5.34 Boston University Company Overview 115

5.34.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 115

5.35 Calmare Therapeutics Inc Company Overview 116

5.35.1 Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.36 CardioCommand Inc Company Overview 117

5.36.1 CardioCommand Inc Pipeline Products & Ongoing Clinical Trials Overview 117

5.37 Cellphire Inc Company Overview 118

5.37.1 Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.38 Ceramicos Para Aplicacoes Medicas SA Company Overview 122

5.38.1 Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 122

5.39 Clemson University Company Overview 123

5.39.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 123

5.40 Cohera Medical Inc Company Overview 124

5.40.1 Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.41 Columbia University Company Overview 127

5.41.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 127

5.42 Covalent Medical, Inc. (Inactive) Company Overview 128

5.42.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

5.43 Covalon Technologies Ltd Company Overview 130

5.43.1 Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

5.44 Covidien Ltd Company Overview 132

5.44.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

5.45 CR Bard Inc Company Overview 133

5.45.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 133

5.46 Cresilon Inc Company Overview 138

5.46.1 Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.47 Department of Biomedical Engineering Columbia University Company Overview 140

5.47.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 140

5.48 DSM Biomedical BV Company Overview 141

5.48.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 141

5.49 Duke University Company Overview 142

5.49.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 142

5.50 Eidgenossische Materialprufungs- und Forschungsanstalt Company Overview 143

5.50.1 Eidgenossische Materialprufungs- und Forschungsanstalt Pipeline Products & Ongoing Clinical Trials Overview 143

5.51 Elastagen Pty Ltd Company Overview 144

5.51.1 Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 144

5.52 Emory University Company Overview 145

5.52.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 145

5.53 Endomedix Incorporated Company Overview 146

5.53.1 Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview 146

5.54 Entegrion Inc Company Overview 148

5.54.1 Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview 148

5.55 Ethicon Endo-Surgery Inc Company Overview 149

5.55.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 149

5.56 Ethicon US LLC Company Overview 150

5.56.1 Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 150

5.57 ETX Pharma Inc Company Overview 155

5.57.1 ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 155

5.58 FzioMed Inc Company Overview 156

5.58.1 FzioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 156

5.59 Gamma Diagnostics Inc Company Overview 159

5.59.1 Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 159

5.60 GATT Technologies BV Company Overview 161

5.60.1 GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview 161

5.61 Genzyme Corp Company Overview 164

5.61.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 164

5.62 Haemostatix Ltd Company Overview 165

5.62.1 Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview 165

5.63 Hangzhou Kangji Medical Instrument Co Ltd Company Overview 167

5.63.1 Hangzhou Kangji Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

5.64 Hemostasis LLC Company Overview 169

5.64.1 Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 169

5.65 HLL Lifecare Ltd Company Overview 171

5.65.1 HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

5.66 HydroGlaze BV Company Overview 172

5.66.1 HydroGlaze BV Pipeline Products & Ongoing Clinical Trials Overview 172

5.67 HyperBranch Medical Technology Inc Company Overview 173

5.67.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 173

5.68 Ichor Sciences LLC Company Overview 175

5.68.1 Ichor Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 175

5.69 Innocoll Technologies Ltd (Inactive) Company Overview 176

5.69.1 Innocoll Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 176

5.70 Institute of Molecular Biology of Parana Company Overview 177

5.70.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 177

5.71 InVivo Therapeutics Corp Company Overview 178

5.71.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 178

5.72 IonMed Ltd. Company Overview 179

5.72.1 IonMed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 179

5.73 Jiangxi Boenruier Biotechnology Co Ltd Company Overview 182

5.73.1 Jiangxi Boenruier Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

5.74 Johns Hopkins University Company Overview 183

5.74.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183

5.75 Keratin Biosciences Inc Company Overview 184

5.75.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 184

5.76 Kollodis BioSciences Inc Company Overview 185

5.76.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.77 Kuros Biosciences AG Company Overview 187

5.77.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 187

5.78 Kytogenics Pharmaceuticals Inc Company Overview 189

5.78.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 189

5.79 Lap IQ Inc Company Overview 190

5.79.1 Lap IQ Inc Pipeline Products & Ongoing Clinical Trials Overview 190

5.80 Laser Tissue Welding, Inc. Company Overview 191

5.80.1 Laser Tissue Welding, Inc. Pipeline Products & Ongoing Clinical Trials Overview 191

5.81 Latch Medical Ltd Company Overview 192

5.81.1 Latch Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 192

5.82 Leader Biomedical Europe BV Company Overview 193

5.82.1 Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview 193

5.83 Lenvitz Medical Solutions Pvt Ltd Company Overview 195

5.83.1 Lenvitz Medical Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

5.84 Life Care Medical Devices Ltd Company Overview 196

5.84.1 Life Care Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 196

5.85 Luna Innovations Inc Company Overview 197

5.85.1 Luna Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview 197

5.86 Magen OrthoMed Ltd Company Overview 199

5.86.1 Magen OrthoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 199

5.87 Massachusetts Institute of Technology Company Overview 201

5.87.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 201

5.88 Maxigen Biotech Inc Company Overview 203

5.88.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 203

5.89 Medcura Inc Company Overview 204

5.89.1 Medcura Inc Pipeline Products & Ongoing Clinical Trials Overview 204

5.90 Medisse BV (Inactive) Company Overview 207

5.90.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 207

5.91 Meril Life Sciences Pvt Ltd Company Overview 210

5.91.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

5.92 MLM Biologics Inc Company Overview 211

5.92.1 MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 211

5.93 N8 Medical LLC Company Overview 213

5.93.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 213

5.94 Nanyang Technological University Company Overview 214

5.94.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 214

5.95 National University of Ireland Galway Company Overview 215

5.95.1 National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview 215

5.96 National University of Singapore Company Overview 216

5.96.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 216

5.97 Northwestern University Company Overview 217

5.97.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 217

5.98 Nurami Medical Ltd Company Overview 218

5.98.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 218

5.99 OptMed, Inc. Company Overview 219

5.99.1 OptMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 219

5.100 PetVivo Holdings Inc Company Overview 222

5.100.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 222

5.101 Pharming Group NV Company Overview 223

5.101.1 Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 223

5.102 Polyganics BV Company Overview 224

5.102.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 224

5.103 PolyNovo Biomaterials Pty Ltd Company Overview 231

5.103.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 231

5.104 Progress and Health Foundation Company Overview 232

5.104.1 Progress and Health Foundation Pipeline Products & Ongoing Clinical Trials Overview 232

5.105 Protege Biomedical LLC Company Overview 233

5.105.1 Protege Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 233

5.106 Protein Polymer Technologies Inc (Inactive) Company Overview 234

5.106.1 Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 234

5.107 Purdue University Company Overview 235

5.107.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 235

5.108 Radiation Monitoring Devices Inc Company Overview 237

5.108.1 Radiation Monitoring Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 237

5.109 Regenics AS Company Overview 238

5.109.1 Regenics AS Pipeline Products & Ongoing Clinical Trials Overview 238

5.110 Resorba GmbH Company Overview 240

5.110.1 Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 240

5.111 Rice University Company Overview 242

5.111.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 242

5.112 Rutgers The State University of New Jersey Company Overview 243

5.112.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 243

5.113 Samyang Biopharmaceuticals Corp Company Overview 244

5.113.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 244

5.114 Sanofi Biosurgery Inc Company Overview 245

5.114.1 Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 245

5.115 Sea Run Holdings Inc Company Overview 247

5.115.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 247

5.116 Sealantis Ltd. Company Overview 249

5.116.1 Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 249

5.117 Seikagaku Corp Company Overview 255

5.117.1 Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview 255

5.118 Seraffix Ltd Company Overview 258

5.118.1 Seraffix Ltd Pipeline Products & Ongoing Clinical Trials Overview 258

5.119 Shanghai Haohai Biological Technology Co Ltd Company Overview 259

5.119.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

5.120 Sporogenics Pte Ltd Company Overview 260

5.120.1 Sporogenics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 260

5.121 St Teresa Medical Inc Company Overview 261

5.121.1 St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 261

5.122 Stanford University Company Overview 263

5.122.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 263

5.123 Starling Surgical Company Overview 264

5.123.1 Starling Surgical Pipeline Products & Ongoing Clinical Trials Overview 264

5.124 STB Lifesaving Technologies Company Overview 265

5.124.1 STB Lifesaving Technologies Pipeline Products & Ongoing Clinical Trials Overview 265

5.125 Surgical Energetics LLC Company Overview 266

5.125.1 Surgical Energetics LLC Pipeline Products & Ongoing Clinical Trials Overview 266

5.126 Surgical Sealants, Inc. Company Overview 267

5.126.1 Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 267

5.127 Tectum Company Overview 268

5.127.1 Tectum Pipeline Products & Ongoing Clinical Trials Overview 268

5.128 Teijin Pharma Ltd Company Overview 270

5.128.1 Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 270

5.129 Tetratherix Pty Ltd Company Overview 271

5.129.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 271

5.130 Texas A&M University Company Overview 272

5.130.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 272

5.131 The Medicines Co Company Overview 274

5.131.1 The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview 274

5.132 TheraCell Inc Company Overview 276

5.132.1 TheraCell Inc Pipeline Products & Ongoing Clinical Trials Overview 276

5.133 Therus Corporation Company Overview 277

5.133.1 Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview 277

5.134 Thrombotargets Corp Company Overview 278

5.134.1 Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview 278

5.135 Tissium SA Company Overview 282

5.135.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview 282

5.136 Toray Medical Co Ltd Company Overview 289

5.136.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 289

5.137 Tribos LLC Company Overview 290

5.137.1 Tribos LLC Pipeline Products & Ongoing Clinical Trials Overview 290

5.138 Tricol Biomedical Inc Company Overview 291

5.138.1 Tricol Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 291

5.139 TYBR Health Inc Company Overview 292

5.139.1 TYBR Health Inc Pipeline Products & Ongoing Clinical Trials Overview 292

5.140 United Health Products, Inc. Company Overview 293

5.140.1 United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 293

5.141 University of Akron Company Overview 298

5.141.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview 298

5.142 University of Grenoble Alpes Company Overview 299

5.142.1 University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview 299

5.143 University of Kansas Company Overview 300

5.143.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 300

5.144 University of Minnesota Company Overview 301

5.144.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 301

5.145 University of North Carolina at Chapel Hill Company Overview 302

5.145.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview 302

5.146 University of Pennsylvania Company Overview 303

5.146.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 303

5.147 University of Toledo Company Overview 304

5.147.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 304

5.148 Virginia Commonwealth University Company Overview 305

5.148.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 305

5.149 WoundZipper Inc Company Overview 306

5.149.1 WoundZipper Inc Pipeline Products & Ongoing Clinical Trials Overview 306

5.150 Xcede Technologies Inc Company Overview 307

5.150.1 Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 307

5.151 Yale University Company Overview 311

5.151.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 311

5.152 Yantai Zhenghai Biological Technology Co Ltd Company Overview 312

5.152.1 Yantai Zhenghai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 312

5.153 Z-Medica LLC Company Overview 313

5.153.1 Z-Medica LLC Pipeline Products & Ongoing Clinical Trials Overview 313

5.154 ZSX Medical LLC Company Overview 316

5.154.1 ZSX Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 316

6 Wound Closure Devices- Recent Developments 317

6.1 May 19, 2022: ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update 317

6.2 May 13, 2022: Cadila Pharma appoints Jawed Zia as CEO 318

6.3 May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference 318

6.4 May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company 318

6.5 May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix 319

6.6 May 10, 2022: Baxter to Host 2022 Investor Conference 319

6.7 May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022 319

6.8 May 05, 2022: Cardinal Health Reports Third Quarter Fiscal 2022 Results 320

6.9 May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results 322

6.10 May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022 325

6.11 May 03, 2022: Owens & Minor Reports First Quarter 2022 Financial Results 325

6.12 May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference 326

6.13 Apr 28, 2022: Kangji Medical Holdings Notice of Annual General Meeting and Declaration of Dividend 327

6.14 Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update 327

6.15 Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022 329

6.16 Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results 331

6.17 Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition 331

6.18 Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference 331

6.19 Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results 331

6.20 Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022 333

6.21 Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference 333

6.22 Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference 333

6.23 Mar 31, 2022: Smith & Nephew announces Directorate Change 333

6.24 Mar 28, 2022: ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update 333

6.25 Mar 28, 2022: Leading medical device company to build Center for Excellence in Cellular Manufacturing in Greater Sacramento (Rancho Cordova) 335

6.26 Mar 22, 2022: Kangji Medical Holdings announces Annual Results Announcement for the Year Ended December 31, 2021 336

6.27 Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results 338

6.28 Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference 338

6.29 Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022 338

6.30 Mar 09, 2022: Owens & Minor to Present at the Barclays Global Healthcare Conference Tuesday, March 15, 2022 339

6.31 Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results 339

6.32 Feb 28, 2022: MIMEDX Announces Fourth Quarter and Full Year 2021 Operating and Financial Results 341

6.33 Feb 22, 2022: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021 343

6.34 Feb 22, 2022: Asahi Kasai Names Company Veteran as New President 344

6.35 Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer 344

6.36 Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors 347

6.37 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference 347

6.38 Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference 348

6.39 Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022 348

6.40 Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference 348

6.41 Feb 03, 2022: Cardinal Health Reports Second Quarter Fiscal 2022 Results 348

6.42 Jan 27, 2022: Johnson & Johnson to Participate in Citi’s 2022 Virtual Healthcare Conference 350

6.43 Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results 350

6.44 Jan 11, 2022: Integra LifeSciences Reports Preliminary Fourth Quarter and Full-Year 2021 Revenue and Plans $125 Million Share Repurchase 351

6.45 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors 352

6.46 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 352

6.47 Jan 04, 2022: Arch Therapeutics Announces Appointment of Guy Fish to the Board 353

6.48 Dec 23, 2021: Olympus to Present at JP Morgan Healthcare Conference 353

6.49 Dec 22, 2021: Sanara MedTech Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors 353

6.50 Dec 22, 2021: United Health Products provides regulatory status update 354

6.51 Dec 15, 2021: Sanara MedTech Announces the Appointment of Roszell Mack III to its Board of Directors 354

6.52 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021 355

6.53 Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results 356

6.54 Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference 356

6.55 Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE 357

6.56 Nov 29, 2021: Owens & Minor to Present at Bank of America Leveraged Finance Conference 357

6.57 Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences 357

6.58 Nov 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2021, and Provides Corporate Update 357

6.59 Nov 09, 2021: Cardinal Health Reports First Quarter Fiscal 2022 Results 359

6.60 Nov 08, 2021: IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan’s High-Quality, Integrated Medical Services to the World 361

6.61 Nov 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2021 and Provide a Corporate Strategic Update 361

6.62 Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results 361

6.63 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference 364

6.64 Nov 02, 2021: MIMEDX Announces Third Quarter 2021 Operating and Financial Results 364

6.65 Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors 366

6.66 Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER 367

6.67 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021 377

6.68 Oct 21, 2021: Owens & Minor will Report Third Quarter Financial Results on Wednesday, November 3, 2021 378

6.69 Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021 379

6.70 Oct 14, 2021: MIMEDX to Host Virtual Investor Day on December 7, 2021 379

6.71 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference 379

6.72 Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021 379

6.73 Oct 12, 2021: AOTI participating in multiple leading global wound care conferences 381

6.74 Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations 381

6.75 Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference 382

6.76 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021 382

6.77 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors 382

6.78 Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors 382

6.79 Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 383

6.80 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021 383

6.81 Sep 09, 2021: InVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright Annual Global Investment Conference 383

6.82 Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 384

6.83 Sep 03, 2021: Realheart enters partnership with software experts Codialist 384

6.84 Sep 02, 2021: Integra LifeSciences Announces Participation In Upcoming Investor Conferences 384

6.85 Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results 384

6.86 Aug 26, 2021: Kangji Medical Holdings Announces Interim Results for the Six Months Ended June 30, 2021 386

6.87 Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022 386

6.88 Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference 388

6.89 Aug 12, 2021: ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2021, and Provides Corporate Update 388

6.90 Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference 390

6.91 Aug 05, 2021: Olympus Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2022 390

6.92 Aug 05, 2021: Cardinal Health reports fourth quarter and full year results for fiscal year 2021 390

6.93 Aug 05, 2021: ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update 392

6.94 Aug 03, 2021: MIMEDX Announces Second Quarter 2021 Operating and Financial Results 393

6.95 Jul 30, 2021: Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan 395

6.96 Jul 29, 2021: Smith+Nephew Second Quarter and First Half 2021 Results 396

6.97 Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results 397

6.98 Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021 399

6.99 Jul 29, 2021: Baxter to Present at UBS Genomics

2.0 and MedTech Innovations Summit 399

6.100 Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results 399

6.101 Jul 29, 2021: Smith & Nephew announces Half-year Report 400

6.102 Jul 28, 2021: Integra LifeSciences Reports Second Quarter 2021 Financial Results 401

6.103 Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference 403

6.104 Jul 27, 2021: Stryker reports second quarter 2021 operating results 404

6.105 Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results 405

6.106 Jul 20, 2021: Owens & Minor will Report Second Quarter Financial Results on Tuesday, August 3, 2021 406

6.107 Jul 20, 2021: MIMEDX to Host Second Quarter 2021 Operating and Financial Results Conference Call on August 4 40

List of Tables

Wound Closure Devices – Pipeline Products by Stage of Development 29

Wound Closure Devices – Pipeline Products by Segment 30

Wound Closure Devices – Pipeline Products by Territory 32

Wound Closure Devices – Pipeline Products by Regulatory Path 34

Wound Closure Devices – Pipeline Products by Estimated Approval Date 35

Wound Closure Devices – Ongoing Clinical Trials 36

Wound Closure Devices Companies – Pipeline Products by Stage of Development 37

Wound Closure Devices – Pipeline Products by Stage of Development 43

3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

PuraStat – Product Status 49

PuraStat – Product Description 50

TDM-623 – Product Status 50

TDM-623 – Product Description 50

3-D Matrix Ltd – Ongoing Clinical Trials Overview 51

PuraStat – A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection 52

PuraStat – A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding 52

PuraStat – A Study to Evaluate the Effectiveness of Purastat in the Prevention of Delayed Bleeding after EMR of Non-ampullary Duodenal Lesions 53

PuraStat – Efficacy of PuraStat for the Prevention of Delayed Bleeding after Endoscopic Resection of Colorectal Lesions 53

PuraStat – Endoscopically-delivered Purastat for the Treatment of Haemorrhagic Radiation Proctopathy: A Randomised Feasibility Study 53

PuraStat – The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery 54

Abyrx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

Soft Tissue Hemostat – Product Status 55

Soft Tissue Hemostat – Product Description 55

ACell Inc Pipeline Products & Ongoing Clinical Trials Overview 56

MicroMatrix – Product Status 56

MicroMatrix – Product Description 57

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

ACROHCM – Product Status 58

ACROHCM – Product Description 58

Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview 59

Actamax Adhesion Barrier – Product Status 59

Actamax Adhesion Barrier – Product Description 59

Actamax Surgical Materials LLC – Ongoing Clinical Trials Overview 60

Actamax Adhesion Barrier – A Randomized, Controlled, Multi-center Study to Assess the Safety and Efficacy of Actamax Adhesion Barrier in Women undergoing Laparoscopic Abdominopelvic Surgery with a Myomectomy Followed by Second Look Laparoscopy (SLL) 61

Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 62

Vivo – Product Status 62

Vivo – Product Description 62

Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Hemocoll – Product Status 63

Hemocoll – Product Description 63

Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 64

Large Wounds Closure Device – Product Status 64

Large Wounds Closure Device – Product Description 64

LiquiBand – Product Status 65

LiquiBand – Product Description 65

LiquiBand XL – Product Status 65

LiquiBand XL – Product Description 66

Next Generation Internal Fixation And Sealant Device – Product Status 66

Next Generation Internal Fixation And Sealant Device – Product Description 66

Advanced Medical Solutions Group plc – Ongoing Clinical Trials Overview 67

LiquiBand – A Prospective Randomized Controlled Trial Comparing Cyanoacrylate Skin Adhesive with Staple for Surgical Incision Closure after Laparoscopic / Robotic Bowel Resection 68

AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview 69

Rivelin Plain Patch – Product Status 69

Rivelin Plain Patch – Product Description 69

Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 70

VersaWrap Adhesion Barrier – Product Status 70

VersaWrap Adhesion Barrier – Product Description 70

Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 71

Biohybrid Membrane – Product Status 71

Biohybrid Membrane – Product Description 71

Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview 72

BP Glue – Product Status 72

BP Glue – Product Description 72

Dural Sealant – Product Status 73

Dural Sealant – Product Description 73

Surgical Sealant – Product Status 73

Surgical Sealant – Product Description 74

Topical Adhesive – Product Status 74

Topical Adhesive – Product Description 74

Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview 75

Tissue-Bonding Adhesive – Product Status 75

Tissue-Bonding Adhesive – Product Description 75

Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Hemaseel HMN Fibrin Sealant – Product Status 76

Hemaseel HMN Fibrin Sealant – Product Description 76

Hemaseel Thrombin Haemostatic Agent – Product Status 77

Hemaseel Thrombin Haemostatic Agent – Product Description 77

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Hemostatic Patch – Product Status 78

Hemostatic Patch – Product Description 78

HYAFF Gel – Product Status 79

HYAFF Gel – Product Description 79

APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

Deep Wound Hemostat – Product Status 80

Deep Wound Hemostat – Product Description 80

ARC Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Discrete – Product Status 81

Discrete – Product Description 81

Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 82

AC5 – Adhesion Prevention – Product Status 82

AC5 – Adhesion Prevention – Product Description 83

AC5 – Burns – Product Status 83

AC5 – Burns – Product Description 83

AC5 – Diabetic Ulcers – Product Status 84

AC5 – Diabetic Ulcers – Product Description 84

AC5 – Pressure Ulcers – Product Status 84

AC5 – Pressure Ulcers – Product Description 85

AC5 – V – Product Status 85

AC5 – V – Product Description 85

AC5 Surgery – Fluid Barrier – Product Status 86

AC5 Surgery – Fluid Barrier – Product Description 86

AC5 Surgery – Laparascopic Procedures – Product Status 86

AC5 Surgery – Laparascopic Procedures – Product Description 87

AC5 Surgery – Open Procedures – Product Status 87

AC5 Surgery – Open Procedures – Product Description 87

AC5 Surgery – Sealant – Product Status 88

AC5 Surgery – Sealant – Product Description 88

AC5 Surgical Hemostatic Device – Product Status 88

AC5 Surgical Hemostatic Device – Product Description 89

AC5-G – Product Status 89

AC5-G – Product Description 89

Arizona State University Pipeline Products & Ongoing Clinical Trials Overview 90

Laser-Activated Nanosealant – Product Status 90

Laser-Activated Nanosealant – Product Description 90

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 91

Bioglue Surgical Adhesive – Product Status 91

Bioglue Surgical Adhesive – Product Description 92

Artivion Inc – Ongoing Clinical Trials Overview 93

Bioglue Surgical Adhesive – Multi-center, Randomized, Controlled Clinical Trial of BioGlue Surgical Adhesive as an Adjunct for Structural Repair and Hemostasis in Chinese Patients with Acute Type A Aortic Dissections 94

Aura Medsystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95

LaSTR – Skin Closure Device – Product Status 95

LaSTR – Skin Closure Device – Product Description 95

BaroStitch Pipeline Products & Ongoing Clinical Trials Overview 96

BaroStitch – Product Status 96

BaroStitch – Product Description 96

Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 97

Celstat Topical Hemostatic Dressing – Product Status 97

Celstat Topical Hemostatic Dressing – Product Description 97

PerClot – Product Status 98

PerClot – Product Description 98

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 99

ACCUREACH – Product Status 99

ACCUREACH – Product Description 99

SEPRALAP – Product Status 100

SEPRALAP – Product Description 100

Tisseel Dura – Product Status 100

Tisseel Dura – Product Description 101

Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 102

Polyurethane Adhesive System – Product Status 102

Polyurethane Adhesive System – Product Description 102

Bergen Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 103

ACTACLOSE – Product Status 103

ACTACLOSE – Product Description 103

Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 104

Portable Wound Hemostasis System – Product Status 104

Portable Wound Hemostasis System – Product Description 104

BioActive Polymers in Lund AB Pipeline Products & Ongoing Clinical Trials Overview 105

BioBarrier – Product Status 105

BioBarrier – Product Description 105

BioDevek Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Adhesive Sealant – Product Status 106

Adhesive Sealant – Product Description 106

Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 107

ClotBlock – Product Status 107

ClotBlock – Product Description 107

ClotFoam – Product Status 108

ClotFoam – Product Description 108

ClotGel – Product Status 108

ClotGel – Product Description 109

ClotSpray – Product Status 109

ClotSpray – Product Description 109

Biom’Up SAS Pipeline Products & Ongoing Clinical Trials Overview 110

HEMOSNOW – Product Status 110

HEMOSNOW – Product Description 111

BNC Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 112

BNC-RB01 – Product Status 112

BNC-RB01 – Product Description 112

BNC-RH01 – Product Status 113

BNC-RH01 – Product Description 113

Borayer Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 114

Biofluid Hemostatic Membrane – Product Status 114

Biofluid Hemostatic Membrane – Product Description 114

Boston University Pipeline Products & Ongoing Clinical Trials Overview 115

Hydrogel-Based Aerosolized Sealant Dressing – Product Status 115

Hydrogel-Based Aerosolized Sealant Dressing – Product Description 115

Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

Wound Sealant – Product Status 116

Wound Sealant – Product Description 116

CardioCommand Inc Pipeline Products & Ongoing Clinical Trials Overview 117

Tournicath Device – Product Status 117

Tournicath Device – Product Description 117

Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview 118

Thromboderm – Product Status 118

Thromboderm – Product Description 118

Thrombosomes – Product Status 119

Thrombosomes – Product Description 119

Cellphire Inc – Ongoing Clinical Trials Overview 120

Thrombosomes – A Phase I, Multi-center, Open-label, Dose Escalation Study of Thrombosomes in Bleeding Thrombocytopenic Patients in Three Cohorts 121

Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview 122

HemoKi – Product Status 122

HemoKi – Product Description 122

Clemson University Pipeline Products & Ongoing Clinical Trials Overview 123

Surgical Adhesive Hydrogel – Product Status 123

Surgical Adhesive Hydrogel – Product Description 123

Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 124

Sylys Surgical Sealant – Drug Delivery – Product Status 124

Sylys Surgical Sealant – Drug Delivery – Product Description 124

Sylys Surgical Sealant – Hernia Mesh Fixation – Product Status 125

Sylys Surgical Sealant – Hernia Mesh Fixation – Product Description 125

Sylys Surgical Sealant – Orthopedic – Product Status 125

Sylys Surgical Sealant – Orthopedic – Product Description 126

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 127

Hemostatic Wound Dressing – Product Status 127

Hemostatic Wound Dressing – Product Description 127

Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

Covabond – Product Status 128

Covabond – Product Description 128

CovaSTAT – Product Status 129

CovaSTAT – Product Description 129

Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 130

ColActive THP – Product Status 130

ColActive THP – Product Description 130

CovaStat BioActive Absorbable Hemostatic Sponge – Product Status 131

CovaStat BioActive Absorbable Hemostatic Sponge – Product Description 131

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Soft Tissue Repair Device – Product Status 132

Soft Tissue Repair Device – Product Description 132

CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 133

Absorbable Hemostat – Product Status 133

Absorbable Hemostat – Product Description 133

New Hemostat 1 – Product Status 134

New Hemostat 1 – Product Description 134

New Hemostat 2 – Product Status 134

New Hemostat 2 – Product Description 134

Progel Dural Sealant – Product Status 135

Progel Dural Sealant – Product Description 135

Progel Emerald – Product Status 135

Progel Emerald – Product Description 135

ProGEL-VS – Product Status 136

ProGEL-VS – Product Description 136

Tissue Adhesive – Product Status 136

Tissue Adhesive – Product Description 137

Tridyne Peripheral – Product Status 137

Tridyne Peripheral – Product Description 137

Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview 138

Hemostatic Gel – Product Status 138

Hemostatic Gel – Product Description 138

TRAUMAGEL – Product Status 139

TRAUMAGEL – Product Description 139

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 140

Biomimetic Lung Sealant – Product Status 140

Biomimetic Lung Sealant – Product Description 140

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 141

Dural Membrane Sealant – Product Status 141

Dural Membrane Sealant – Product Description 141

Duke University Pipeline Products & Ongoing Clinical Trials Overview 142

Intrauterine Adhesion Barrier – Product Status 142

Intrauterine Adhesion Barrier – Product Description 142

Eidgenossische Materialprufungs- und Forschungsanstalt Pipeline Products & Ongoing Clinical Trials Overview 143

Polymer Patch – Product Status 143

Polymer Patch – Product Description 143

Elastagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 144

MeTro – Surgical Glue – Product Status 144

MeTro – Surgical Glue – Product Description 144

Emory University Pipeline Products & Ongoing Clinical Trials Overview 145

Steroidal Hemostatic Surgical Adhesive – Product Status 145

Steroidal Hemostatic Surgical Adhesive – Product Description 145

Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview 146

Surgical Hemostat – Intracranial Surgery – Product Status 146

Surgical Hemostat – Intracranial Surgery – Product Description 146

Topical Hemostat – Product Status 147

Topical Hemostat – Product Description 147

Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview 148

Stasix – Product Status 148

Stasix – Product Description 148

Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 149

Bioseal Next Gen Device – Product Status 149

Bioseal Next Gen Device – Product Description 149

Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview 150

Next Gen Hemostat Kit – Product Status 150

Next Gen Hemostat Kit – Product Description 150

PRINEO Next Generation – Product Status 151

PRINEO Next Generation – Product Description 151

SURGIFLO – Sterile Field Preparation – Product Status 151

SURGIFLO – Sterile Field Preparation – Product Description 152

Ethicon US LLC – Ongoing Clinical Trials Overview 153

PRINEO Next Generation – The Effects of Post-Operative Interventions on Surgical Site Occurrences in Abdominal Wall Reconstructions: A Randomized Controlled Trial 154

ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 155

ETX-302 – Product Status 155

ETX-302 – Product Description 155

FzioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 156

Oxiplex – Product Status 156

Oxiplex – Product Description 156

Oxiplex/AP – Product Status 157

Oxiplex/AP – Product Description 157

Oxiplex/IU – Product Status 157

Oxiplex/IU – Product Description 158

Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 159

GammaSeal – Product Status 159

GammaSeal – Product Description 159

GammaTF – Product Status 160

GammaTF – Product Description 160

GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview 161

GATT-Patch – Product Status 161

GATT-Patch – Product Description 161

GATT-Powder – Product Status 162

GATT-Powder – Product Description 162

GATT-Spray – Product Status 162

GATT-Spray – Product Description 163

GATT-Tape – Product Status 163

GATT-Tape – Product Description 163

Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 164

Sepraspray Adhesion Barrier – Product Status 164

Sepraspray Adhesion Barrier – Product Description 164

Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview 165

Haemoplax – Product Status 165

Haemoplax – Product Description 165

PeproStat – Product Status 166

PeproStat – Product Description 166

Hangzhou Kangji Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

Absorbable Clips – Product Status 167

Absorbable Clips – Product Description 167

Automatic-Loading Ligation Clips & Applier – Product Status 168

Automatic-Loading Ligation Clips & Applier – Product Description 168

Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 169

Advanced Tissue Sealant – Product Status 169

Advanced Tissue Sealant – Product Description 169

ENT Hemostat – Product Status 170

ENT Hemostat – Product Description 170

Hemostatic Gel – Product Status 170

Hemostatic Gel – Product Description 170

HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

Hinstat Ext – Product Status 171

Hinstat Ext – Product Description 171

HydroGlaze BV Pipeline Products & Ongoing Clinical Trials Overview 172

HydroGlaze – Product Status 172

HydroGlaze – Product Description 172

HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 173

Adherus Vascular Sealant – Product Status 173

Adherus Vascular Sealant – Product Description 173

Tissue Plane Sealant – Product Status 174

Tissue Plane Sealant – Product Description 174

Ichor Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 175

Statbond ENT – Product Status 175

Statbond ENT – Product Description 175

Innocoll Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 176

CM004 – Product Status 176

CM004 – Product Description 176

Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 177

Recombinant Fibrin Glue – Product Status 177

Recombinant Fibrin Glue – Product Description 177

InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 178

InVivoSeal – Product Status 178

InVivoSeal – Product Description 178

IonMed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 179

BioWeld1 System – Acne – Product Status 179

BioWeld1 System – Acne – Product Description 179

BioWeld1 System – Burns And Chronic Wounds – Product Status 180

BioWeld1 System – Burns And Chronic Wounds – Product Description 180

BioWeld1 System – Skin Graft Fixation – Product Status 180

BioWeld1 System – Skin Graft Fixation – Product Description 181

Jiangxi Boenruier Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 182

Fluid Hemostatic Agent – Product Status 182

Fluid Hemostatic Agent – Product Description 182

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183

Chondroitin Sulfate-based Adhesive – Product Status 183

Chondroitin Sulfate-based Adhesive – Product Description 183

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 184

Keratin-Based Hemostat – Product Status 184

Keratin-Based Hemostat – Product Description 184

Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 185

Cartilage Adhesive – Product Status 185

Cartilage Adhesive – Product Description 185

Hemostat Sealant – Product Status 186

Hemostat Sealant – Product Description 186

Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 187

KUR – 211 – Product Status 187

KUR – 211 – Product Description 187

KUR – 212 – Product Status 188

KUR – 212 – Product Description 188

Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 189

Adhes-X – Product Status 189

Adhes-X – Product Description 189

Lap IQ Inc Pipeline Products & Ongoing Clinical Trials Overview 190

FAStlink – Product Status 190

FAStlink – Product Description 190

Laser Tissue Welding, Inc. Pipeline Products & Ongoing Clinical Trials Overview 191

Laser Tissue Welding Device – Product Status 191

Laser Tissue Welding Device – Product Description 191

Latch Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 192

Relialoc Skin Closure System – Product Status 192

Relialoc Skin Closure System – Product Description 192

Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview 193

Collagen-Based Haemostatic Device – Product Status 193

Collagen-Based Haemostatic Device – Product Description 193

Rebasol – Product Status 194

Rebasol – Product Description 194

Lenvitz Medical Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

Auto Clip Applicator – Product Status 195

Auto Clip Applicator – Product Description 195

Life Care Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 196

LCMD-004 – Product Status 196

LCMD-004 – Product Description 196

Luna Innovations Inc Pipeline Products & Ongoing Clinical Trials Overview 197

Sutureless Absorbable Antiadhesion Film – Product Status 197

Sutureless Absorbable Antiadhesion Film – Product Description 197

TissuCoat – Product Status 198

TissuCoat – Product Description 198

Magen OrthoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 199

NerveShield – Product Status 199

NerveShield – Product Description 199

TendonShield – Product Status 200

TendonShield – Product Description 200

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 201

Double-Sided Tape – Product Status 201

Double-Sided Tape – Product Description 201

Surgical Tape – Product Status 202

Surgical Tape – Product Description 202

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 203

MaxiGel – Product Status 203

MaxiGel – Product Description 203

Medcura Inc Pipeline Products & Ongoing Clinical Trials Overview 204

Hemogrip Foam – Product Status 204

Hemogrip Foam – Product Description 204

LifeDust – Product Status 205

LifeDust – Product Description 205

LifeFoam – Product Status 205

LifeFoam – Product Description 206

LifeGel – Product Status 206

LifeGel – Product Description 206

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 207

FlexiSurge Adhesive Barrier – Product Status 207

FlexiSurge Adhesive Barrier – Product Description 207

PTMC Adhesive – Product Status 208

PTMC Adhesive – Product Description 208

PTMC Sealant – Product Status 208

PTMC Sealant – Product Description 209

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 210

PeriTi – Product Status 210

PeriTi – Product Description 210

MLM Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 211

Adhesion Barrier – Product Status 211

Adhesion Barrier – Product Description 211

Biologic Barrier Membrane – Superficial Wounds – Product Status 212

Biologic Barrier Membrane – Superficial Wounds – Product Description 212

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 213

Tissue Glue & Microbial Sealent – Product Status 213

Tissue Glue & Microbial Sealent – Product Description 213

Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 214

CaproGlu – Product Status 214

CaproGlu – Product Description 214

National University of Ireland Galway Pipeline Products & Ongoing Clinical Trials Overview 215

Bio-Inspired Polymeric Adhesive – Product Status 215

Bio-Inspired Polymeric Adhesive – Product Description 215

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 216

Colon Patch – Product Status 216

Colon Patch – Product Description 216

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 217

Medical Adhesive – Product Status 217

Medical Adhesive – Product Description 217

Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 218

ArtiFix – Product Status 218

ArtiFix – Product Description 218

OptMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 219

Biosurgical Adhesive – Chronic Wounds – Product Status 219

Biosurgical Adhesive – Chronic Wounds – Product Description 219

Biosurgical Adhesive – Internal Use – Product Status 220

Biosurgical Adhesive – Internal Use – Product Description 220

Biosurgical Adhesive – Skin Tears – Product Status 220

Biosurgical Adhesive – Skin Tears – Product Description 221

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 222

Vasculitus Wound Closure Device – Product Status 222

Vasculitus Wound Closure Device – Product Description 222

Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 223

Recombinant Fibrin Tissue Sealant – Product Status 223

Recombinant Fibrin Tissue Sealant – Product Description 223

Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 224

3D Printed Scaffold – Product Status 224

3D Printed Scaffold – Product Description 224

ACTISEAL – Product Status 225

ACTISEAL – Product Description 225

ACTISEAL – Adjacent Indications – Product Status 225

ACTISEAL – Adjacent Indications – Product Description 226

LIQOSEAL – Dura Sealing Patch – Product Status 226

LIQOSEAL – Dura Sealing Patch – Product Description 226

LIQOSEAL – Spine Application – Product Status 227

LIQOSEAL – Spine Application – Product Description 227

Polyganics BV – Ongoing Clinical Trials Overview 228

LIQOSEAL – Dura Sealing Patch – Randomized, Two-arm, Multicenter Study to Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery 229

ACTISEAL – Prospective, Multicenter Study to Evaluate the Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage Following Elective hepatobiLiary and Pancreatic Surgery 230

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 231

Anti-Adhesion Film – Product Status 231

Anti-Adhesion Film – Product Description 231

Progress and Health Foundation Pipeline Products & Ongoing Clinical Trials Overview 232

Wound Closure Kit – Product Status 232

Wound Closure Kit – Product Description 232

Protege Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 233

Ionic Hemostatic Mineral Bandage – Emergency Trauma – Product Status 233

Ionic Hemostatic Mineral Bandage – Emergency Trauma – Product Description 233

Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 234

Surgical Tissue Sealant – Product Status 234

Surgical Tissue Sealant – Product Description 234

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 235

Surgical Adhesive – Product Status 235

Surgical Adhesive – Product Description 235

Surgical Sealant – Product Status 236

Surgical Sealant – Product Description 236

Radiation Monitoring Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 237

Hemostatic Patch – Traumatic Injury – Product Status 237

Hemostatic Patch – Traumatic Injury – Product Description 237

Regenics AS Pipeline Products & Ongoing Clinical Trials Overview 238

Collex – Product Status 238

Collex – Product Description 238

Vernex – Product Status 239

Vernex – Product Description 239

Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview 240

Antibiotic Hemostat – Product Status 240

Antibiotic Hemostat – Product Description 240

RESORBA – Cardiac Surgery – Product Status 241

RESORBA – Cardiac Surgery – Product Description 241

Rice University Pipeline Products & Ongoing Clinical Trials Overview 242

KOD Hydrogel Hemostat – Product Status 242

KOD Hydrogel Hemostat – Product Description 242

Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 243

Biodegradable Film Implant – Product Status 243

Biodegradable Film Implant – Product Description 243

Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 244

Surgical Sealant – Product Status 244

Surgical Sealant – Product Description 244

Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 245

LeSeal – Product Status 245

LeSeal – Product Description 245

Lumagel – Product Status 246

Lumagel – Product Description 246

Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 247

SEA-STAT – Product Status 247

SEA-STAT – Product Description 247

SEA-STAT CNS – Product Status 248

SEA-STAT CNS – Product Description 248

Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 249

Seal-G – Product Status 249

Seal-G – Product Description 249

Seal-G MIST – Product Status 250

Seal-G MIST – Product Description 250

Sealantis Tissue Adhesive – Product Status 250

Sealantis Tissue Adhesive – Product Description 251

Sealantis Ltd. – Ongoing Clinical Trials Overview 252

Seal-G – Seal-G and Seal-G MIST Study for Reinforcement and Protection of Colonic Anastomoses in Subjects Undergoing Colonic Resection 253

Seal-G MIST – Seal-G and Seal-G MIST Study for Reinforcement and Protection of Colonic Anastomoses in Subjects Undergoing Colonic Resection 254

Seikagaku Corp Pipeline Products & Ongoing Clinical Trials Overview 255

SI-449 Adhesion Barrier System – Product Status 255

SI-449 Adhesion Barrier System – Product Description 255

Seikagaku Corp – Ongoing Clinical Trials Overview 256

SI-449 Adhesion Barrier System – A Randomized, Controlled, Pivotal Study of SI-449 Adhesion Barrier in Patients with Temporary Ileostomy 257

Seraffix Ltd Pipeline Products & Ongoing Clinical Trials Overview 258

Seraffix LTB – Product Status 258

Seraffix LTB – Product Description 258

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

Fibrin Sealant Powder – Product Status 259

Fibrin Sealant Powder – Product Description 259

Sporogenics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 260

Anti-Adhesion Barrier Film – Product Status 260

Anti-Adhesion Barrier Film – Product Description 260

St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 261

Surgiclot – Product Status 261

Surgiclot – Product Description 261

WRAPCLOT – Product Status 262

WRAPCLOT – Product Description 262

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 263

Feeding Tube Site Closure Device – Product Status 263

Feeding Tube Site Closure Device – Product Description 263

Starling Surgical Pipeline Products & Ongoing Clinical Trials Overview 264

QuickStitch – Product Status 264

QuickStitch – Product Description 264

STB Lifesaving Technologies Pipeline Products & Ongoing Clinical Trials Overview 265

FAST Dressing – Product Status 265

FAST Dressing – Product Description 265

Surgical Energetics LLC Pipeline Products & Ongoing Clinical Trials Overview 266

FiberSecure – Product Status 266

FiberSecure – Product Description 266

Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 267

Thorex – Product Status 267

Thorex – Product Description 267

Tectum Pipeline Products & Ongoing Clinical Trials Overview 268

Hemostatic Gel – Product Status 268

Hemostatic Gel – Product Description 268

Wound Dressing With Hemostat – Product Status 268

Wound Dressing With Hemostat – Product Description 269

Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 270

KTF-374 Fibrin Sealant – Product Status 270

KTF-374 Fibrin Sealant – Product Description 270

Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 271

Tetragraft – Product Status 271

Tetragraft – Product Description 271

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 272

Tissue Welding Device – Product Status 272

Tissue Welding Device – Product Description 272

Wound Healing And Tissue Repair Bandage – Product Status 273

Wound Healing And Tissue Repair Bandage – Product Description 273

The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview 274

Fibropad Patch – Product Status 274

Fibropad Patch – Product Description 274

Prevent GI Sealant – Product Status 275

Prevent GI Sealant – Product Description 275

TheraCell Inc Pipeline Products & Ongoing Clinical Trials Overview 276

Oxygenated Wound Dressing – Product Status 276

Oxygenated Wound Dressing – Product Description 276

Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview 277

Therus Acoustic Hemostasis System – Product Status 277

List of Figures

Wound Closure Devices – Pipeline Products by Stage of Development 29

Wound Closure Devices – Pipeline Products by Segment 30

Wound Closure Devices – Pipeline Products by Territory 32

Wound Closure Devices – Pipeline Products by Regulatory Path 34

Wound Closure Devices – Pipeline Products by Estimated Approval Date 35

Wound Closure Devices – Ongoing Clinical Trials 36

Frequently Asked Questions

The key territories in the wound closure devices market are United States, Europe, China, South Korea, Japan, Israel, India, Singapore, Taiwan, the United Kingdom. The US has the highest number of pipeline products in the wound closure devices market.

The key segments in the wound closure devices market are Topical Absorbable Hemostats, Tissue Sealants, Tissue Adhesives, Surgical Adhesion Barriers, Synthetic Tissue Sealants, Gel Surgical Adhesion Barriers, Collagen Based Hemostats, Fibrin Based Tissue Sealants, Oxidized Regenerated Cellulose Based Hemostats, Thrombin Based Hemostats, and Membrane Surgical Adhesion Barriers. Topical Absorbable Hemostats has the highest number of pipeline products.

The key regulatory paths in the wound closure devices market are 510(k), CE, PMA, NMPA, MDITAC, ICAC, Ninsho, HAS, MDL, BOPA, and others. 510(k) has the highest number of pipeline products.

The key companies in the wound closure devices market are 3-D Matrix Ltd, Abyrx, Inc., ACell Inc, Acro Biomedical Co Ltd, Actamax Surgical Materials LLC, Adhesys Medical GmbH, Advanced Biotech Products Pvt Ltd, Advanced Medical Solutions Group plc, AFYX Therapeutics A/S, and Alafair Biosciences Inc.

$4000

Can be used by individual purchaser only

$12000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.